Compare AROC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AROC | BRKR |
|---|---|---|
| Founded | 1990 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.2B |
| IPO Year | 2007 | 2000 |
| Metric | AROC | BRKR |
|---|---|---|
| Price | $38.03 | $34.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $40.00 | ★ $48.54 |
| AVG Volume (30 Days) | 1.3M | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.32% | 0.55% |
| EPS Growth | ★ 74.29 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | $1,489,818,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | $7.06 | $6.30 |
| Revenue Next Year | $5.27 | $3.81 |
| P/E Ratio | $20.77 | ★ N/A |
| Revenue Growth | ★ 28.70 | N/A |
| 52 Week Low | $21.17 | $28.53 |
| 52 Week High | $38.16 | $56.22 |
| Indicator | AROC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 65.85 | 35.90 |
| Support Level | $34.30 | $32.74 |
| Resistance Level | N/A | $35.15 |
| Average True Range (ATR) | 1.00 | 1.65 |
| MACD | 0.19 | -0.47 |
| Stochastic Oscillator | 85.28 | 4.47 |
Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.